UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

The New England journal of medicine, 2021-01, Vol.384 (4), p.325-334

2021

Volltextzugriff (PDF)

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study): A Randomized Controlled Trial

Chest, 2012-12, Vol.142 (6), p.1383-1390

2012

Volltextzugriff (PDF)

Diverse forms of pulmonary hypertension remodel the arterial tree to a high shear phenotype

American journal of physiology. Heart and circulatory physiology, 2014-08, Vol.307 (3), p.H405-H417

2014

Volltextzugriff (PDF)

6.6-Hour Inhalation of Ozone Concentrations from 60 to 87 Parts per Billion in Healthy Humans

American journal of respiratory and critical care medicine, 2009-08, Vol.180 (3), p.265-272

2009

Volltextzugriff (PDF)

An expert panel delphi consensus statement on patient selection and management for transitioning between oral and inhaled treprostinil

Pulmonary pharmacology & therapeutics, 2021-02, Vol.66, p.101979-101979, Article 101979

2021

Volltextzugriff (PDF)

A diagnosis at hand: pulmonary arterial hypertension

The American journal of medicine, 2016-08, Vol.129 (8), p.812-815

2016

Volltextzugriff (PDF)

Analysis of volatile compounds in exhaled breath condensate in patients with severe pulmonary arterial hypertension

PloS one, 2014-04, Vol.9 (4), p.e95331-e95331

2014

Volltextzugriff (PDF)

Long-term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokinetics

Pulmonary circulation, 2020-10, Vol.10 (4), p.1-9

2020

Volltextzugriff (PDF)

Transition from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension: a controlled trial

Chest, 2007-09, Vol.132 (3), p.757

2007

Volltextzugriff (PDF)

Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulation

Pulmonary circulation, 2017-01, Vol.7 (1), p.167-174

2017

Volltextzugriff (PDF)

Balloon dilation atrial septostomy for advanced pulmonary hypertension in patients on prostanoid therapy

Catheterization and cardiovascular interventions, 2015-05, Vol.85 (6), p.1066-1072

2015

Volltextzugriff (PDF)

Do airway metallic stents for benign lesions confer too costly a benefit?

BMC pulmonary medicine, 2008-04, Vol.8 (1), p.7-7, Article 7

2008

Volltextzugriff (PDF)

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study)

Chest, 2012-12, Vol.142 (6), p.1383-1390

2012

Volltextzugriff (PDF)

Exhaled volatile organic compounds in individuals with a history of high altitude pulmonary edema and varying hypoxia-induced responses

Journal of breath research, 2015-04, Vol.9 (2), p.026004-026004

2015

Volltextzugriff (PDF)

Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension: A Randomized, Controlled Trial

Circulation (New York, N.Y.), 2013-02, Vol.127 (5), p.624-633

2013

Volltextzugriff (PDF)

FREEDOM-M: Efficacy and Safety of Oral Treprostinil Diethanolamine as Monotherapy in Patients With Pulmonary Arterial Hypertension

Chest, 2011-10, Vol.140 (4), p.1044A-1044B

2011

Volltextzugriff (PDF)

Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry

Journal of the American Heart Association, 2022-05, Vol.11 (9), p.e024969-e024969

2022

Volltextzugriff (PDF)

Bronchiolitis obliterans

Clinical reviews in allergy & immunology, 2003-12, Vol.25 (3), p.259-274

2003

Volltextzugriff (PDF)

Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial

The Lancet (British edition), 2011-09, Vol.378 (9795), p.997-1005

2011

Volltextzugriff (PDF)

Advances in the management of endobronchial lung malignancies

Current opinion in pulmonary medicine, 2003-07, Vol.9 (4), p.301-308

2003

Volltextzugriff (PDF)

Transition From IV Epoprostenol to Subcutaneous Treprostinil in Pulmonary Arterial Hypertension

Chest, 2007-09, Vol.132 (3), p.757-763

2007

Volltextzugriff (PDF)

Pharmacokinetics of Oral Treprostinil Sustained Release Tablets During Chronic Administration to Patients with Pulmonary Arterial Hypertension

Journal of cardiovascular pharmacology, 2013-06, Vol.61 (6), p.474-481

2013

Volltextzugriff (PDF)

Micro-optical fabrication by ultraprecision diamond machining and precision molding

Frontiers of Mechanical Engineering, 2017-06, Vol.12 (2), p.181-192

2017

Volltextzugriff (PDF)

Obesity in Pulmonary Arterial Hypertension (PAH): The Pulmonary Hypertension Association Registry (PHAR)

Annals of the American Thoracic Society, 2021-02, Vol.18 (2), p.229-237

2021

Volltextzugriff (PDF)

The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema

Journal of bronchology & interventional pulmonology, 2014-10, Vol.21 (4), p.288-297

2014

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(49)

Publikationsform

Artikel
(56)

Sprache

Englisch
(56)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study): A Randomized Controlled Trial

Diverse forms of pulmonary hypertension remodel the arterial tree to a high shear phenotype

6.6-Hour Inhalation of Ozone Concentrations from 60 to 87 Parts per Billion in Healthy Humans

An expert panel delphi consensus statement on patient selection and management for transitioning between oral and inhaled treprostinil

A diagnosis at hand: pulmonary arterial hypertension

Analysis of volatile compounds in exhaled breath condensate in patients with severe pulmonary arterial hypertension

Long-term study of oral treprostinil to treat pulmonary arterial hypertension: dosing, tolerability, and pharmacokinetics

Transition from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension: a controlled trial

Recommendations for the use of oral treprostinil in clinical practice: a Delphi consensus project pulmonary circulation

Balloon dilation atrial septostomy for advanced pulmonary hypertension in patients on prostanoid therapy

Do airway metallic stents for benign lesions confer too costly a benefit?

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients on Background Endothelin Receptor Antagonist and/or Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C Study)

Exhaled volatile organic compounds in individuals with a history of high altitude pulmonary edema and varying hypoxia-induced responses

Efficacy and Safety of Oral Treprostinil Monotherapy for the Treatment of Pulmonary Arterial Hypertension: A Randomized, Controlled Trial

FREEDOM-M: Efficacy and Safety of Oral Treprostinil Diethanolamine as Monotherapy in Patients With Pulmonary Arterial Hypertension

Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry

Bronchiolitis obliterans

Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial

Advances in the management of endobronchial lung malignancies

Transition From IV Epoprostenol to Subcutaneous Treprostinil in Pulmonary Arterial Hypertension

Pharmacokinetics of Oral Treprostinil Sustained Release Tablets During Chronic Administration to Patients with Pulmonary Arterial Hypertension

Micro-optical fabrication by ultraprecision diamond machining and precision molding

Obesity in Pulmonary Arterial Hypertension (PAH): The Pulmonary Hypertension Association Registry (PHAR)

The IBV Valve trial: a multicenter, randomized, double-blind trial of endobronchial therapy for severe emphysema

Suchergebnisse filtern